Enhancing X‐Ray Sensitization with Multifunctional Nanoparticles

Author:

Liu Jiayi1ORCID,Wu JunYong2,Chen Taili3,Yang Bin4,Liu XiangPing5,Xi Jing6,Zhang Ziyang78,Gao Yawen1,Li ZhiHong910

Affiliation:

1. Department of Oncology The Second Xiangya Hospital Central South University Changsha Hunan Province 410011 China

2. Department of Pharmacy The Second Xiangya Hospital Central South University Changsha Hunan Province 410011 China

3. Department of Oncology Xiangya Hospital Central South University Changsha Hunan Province 410008 China

4. Department of Orthopedics Shaodong People's Hospital Shaoyang Hunan Province 422800 China

5. Department of Neurology Shaodong People's Hospital Shaoyang Hunan Province 422800 China

6. Department of Nephrology Changde Hospital, Xiangya School of Medicine Central South University (The First People's Hospital of Changde City) Changde Hunan Province 415000 China

7. Department of Biomedical Engineering College of Design and Engineering National University of Singapore Singapore 119276 Singapore

8. Department of Pharmacy and Pharmaceutical Sciences Faculty of Science National University of Singapore Singapore 117544 Singapore

9. Department of Orthopedics The Second Xiangya Hospital Central South University Changsha Hunan Province 410011 China

10. Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital Central South University Changsha Hunan Province 410011 China

Abstract

AbstractIn the progression of X‐ray‐based radiotherapy for the treatment of cancer, the incorporation of nanoparticles (NPs) has a transformative impact. This study investigates the potential of NPs, particularly those comprised of high atomic number elements, as radiosensitizers. This aims to optimize localized radiation doses within tumors, thereby maximizing therapeutic efficacy while preserving surrounding tissues. The multifaceted applications of NPs in radiotherapy encompass collaborative interactions with chemotherapeutic, immunotherapeutic, and targeted pharmaceuticals, along with contributions to photodynamic/photothermal therapy, imaging enhancement, and the integration of artificial intelligence technology. Despite promising preclinical outcomes, the paper acknowledges challenges in the clinical translation of these findings. The conclusion maintains an optimistic stance, emphasizing ongoing trials and technological advancements that bolster personalized treatment approaches. The paper advocates for continuous research and clinical validation, envisioning the integration of NPs as a revolutionary paradigm in cancer therapy, ultimately enhancing patient outcomes.

Publisher

Wiley

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3